Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center, Open-Label Randomized Study of Single or Double Myeloablative Cord Blood Transplantation With or Without Infusion of Off-The-Shelf Ex Vivo Expanded Cryopreserved Cord Blood Progenitor Cells in Patients With Hematologic Malignancies

NCT01690520 is registered in ClinicalTrials.gov with Nohla Therapeutics, Inc. as lead sponsor.

NCT NCT01690520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01690520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center, Open-Label Randomized Study of Single or Double Myeloablative Cord Blood Transplantation With or Without Infusion of Off-The-Shelf Ex Vivo Expanded Cryopreserved Cord Blood Progenitor Cells in Patients With Hematologic Malignancies
Lead sponsor
Nohla Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 11, 2012
Completion date
May 29, 2020
Enrollment
163 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute biphenotypic leukemia, acute lymphoblastic leukemia in remission, acute myeloid leukemia in remission, chronic myelogenous leukemia, myelodysplastic syndrome